RYR2 and Malignant hyperthermia: Earlier studies by Treves and colleagues demonstrated that mutations of RyR1 in human patients with malignant hyperthermia and central core disease impacted IL-6 release from skeletal muscle58, which is consistent with the role of RyR-mediated calcium release in modulation of inflammatory cytokine release.